LYMPHOLOGY
Scope & Guideline
Connecting theory and practice in lymphology.
Introduction
Aims and Scopes
- Clinical Management of Lymphatic Disorders:
The journal emphasizes research on clinical interventions and management strategies for conditions like lymphedema, lipedema, and other lymphatic disorders, aiming to improve patient outcomes. - Innovative Therapeutic Approaches:
Studies frequently explore novel therapeutic techniques, such as acupuncture, cryotherapy, and shock wave therapy, highlighting their potential roles in treating lymphatic conditions. - Pathophysiological Insights:
Research often delves into the underlying biological mechanisms of lymphatic disorders, including genetic studies and the impact of cancer treatments on lymphatic function. - Multidisciplinary Perspectives:
The journal encourages a multidisciplinary approach, incorporating insights from oncology, genetics, and rehabilitation to provide a comprehensive view of lymphatic health. - Systematic Reviews and Meta-Analyses:
The publication of systematic reviews underscores the importance of synthesizing existing research to inform best practices in lymphology.
Trending and Emerging
- Integration of Technology in Treatment:
Emerging studies are increasingly focusing on the use of advanced imaging techniques and technology-driven therapies, such as bioimpedance spectroscopy and lymphoscintigraphy, to enhance diagnostic accuracy and treatment efficacy. - Holistic and Multimodal Treatment Approaches:
There is a growing trend towards exploring holistic treatment strategies that combine various modalities, including manual lymphatic drainage, kinesiology taping, and psychological interventions, to address the multifaceted nature of lymphatic disorders. - Impact of Cancer Treatments on Lymphatic Health:
With an increasing number of cancer survivors, research is trending towards understanding the long-term effects of cancer treatments on lymphatic health, particularly in relation to lymphedema and associated complications. - Patient-Centered Care and Quality of Life Assessments:
Emerging themes include the assessment of patient-reported outcomes, self-efficacy, and quality of life in individuals with lymphatic disorders, reflecting a shift towards more patient-centered research. - Genetic and Molecular Studies:
There is a rising interest in genetic predispositions and molecular mechanisms underlying lymphatic diseases, which could lead to targeted therapies and personalized medicine approaches.
Declining or Waning
- Historical Perspectives on Lymphology:
There has been a noticeable reduction in papers focusing on historical analyses and retrospective studies related to lymphatic disorders, suggesting a shift towards more contemporary and forward-looking research. - Basic Science Research:
Research that primarily emphasizes basic science aspects of lymphatics, such as lymphatic embryology or fundamental cellular mechanisms, has decreased, possibly indicating a growing preference for clinical applications and translational research. - Single Case Studies:
The frequency of single case studies appears to be waning as the journal prioritizes larger cohort studies and systematic reviews that provide broader insights into lymphatic conditions.
Similar Journals
Research and Practice in Thrombosis and Haemostasis
Innovating hematology through open-access insights.Research and Practice in Thrombosis and Haemostasis, published by Elsevier, is a prominent open-access journal dedicated to advancing the field of hematology through high-quality research and clinical practice. Since its inception in 2017, this journal has established itself as a vital resource for researchers, healthcare professionals, and students interested in thrombosis and hemorrhage management, showcasing original research, reviews, and clinical studies. The journal’s commitment to accessible knowledge is reflected in its open-access model, allowing researchers worldwide to share their findings without financial barriers. With an impressive 2023 Scopus rank of #42 out of 137 in the hematology category and a respectable Q2 classification, it provides an authoritative platform for innovative ideas and cutting-edge developments in the field. As the journal continues to grow in stature, it aims to foster collaboration and knowledge exchange amongst professionals dedicated to improving patient outcomes in thrombosis and hemostasis.
BLOOD REVIEWS
Elevating knowledge in blood disorders and cancer care.BLOOD REVIEWS is a highly regarded journal published by Churchill Livingstone, specializing in the fields of Hematology and Oncology. With an impressive Q1 ranking in both disciplines and placing in the top 10% of its peer categories according to Scopus metrics, it provides an essential platform for the dissemination of cutting-edge research and reviews pertaining to blood disorders and cancer treatment. Since its inception in 1987 and continuing through 2024, the journal has established itself as a cornerstone for healthcare professionals, researchers, and students who seek to advance their understanding of hematologic and oncologic topics. While not an open-access journal, BLOOD REVIEWS retains a reputation for delivering high-quality, peer-reviewed articles that foster dialogue and innovation within the scientific community. For those in the United States and beyond, the journal serves as a vital resource, housed at the Journal Production Department in Edinburgh, Scotland, ensuring accessibility and a global reach in its critical academic contributions.
Blood Research
Exploring the Frontiers of Hematology ResearchBlood Research, published by SPRINGER, is a premier journal dedicated to the multifaceted realm of hematology, serving as a crucial platform for disseminating innovative research findings and advancements in the diagnosis and treatment of blood-related disorders. With an ISSN of 2287-979X and an E-ISSN of 2288-0011, this journal is recognized for its commitment to scholarly excellence and impact in the field, currently holding a reputable Q2 ranking in the Hematology category as per the 2023 metrics. The journal spans from 2013 to 2024, providing a broad archive of quality research that is vital for researchers, healthcare professionals, and students alike. Although it is not an Open Access journal, it offers insightful contributions that enhance the understanding of hematological science, fostering the exchange of knowledge crucial for advancing patient care and clinical practices globally. The journal’s performance is underscored by its Scopus ranking in the 46th percentile, reflecting its significant role in the ongoing discourse in hematology.
British Journal of Pain
Fostering Knowledge for Pain-Free FuturesThe British Journal of Pain is a leading publication in the field of Anesthesiology and Pain Medicine, expertly published by SAGE Publications Ltd from the United Kingdom. With an ISSN of 2049-4637 and an E-ISSN of 2049-4645, this journal has established itself as an essential resource for researchers and practitioners alike, achieving an impressive Q2 ranking in its category for 2023, as well as a Scopus rank of #53 out of 136 in Medicine – Anesthesiology and Pain Medicine. The journal spans a broad scope of topics related to pain management, therapeutic practices, and advancements in treatment methodologies, catering to both ongoing research and clinical applications. Researchers and professionals can access a wealth of knowledge that not only supports the academic community but also drives innovative practices in pain management. The British Journal of Pain recognizes the significance of evidence-based research and its application in clinical settings, making it a vital platform for advancing the understanding of pain and improving patient care.
Blood and Lymphatic Cancer-Targets and Therapy
Exploring New Horizons in Cancer TherapyBlood and Lymphatic Cancer-Targets and Therapy, published by DOVE MEDICAL PRESS LTD, is a vital open-access journal that has been disseminating crucial research and findings in the field of hematology and oncology since 2011. With its ISSN 1179-9889, this journal focuses on the latest therapeutic targets and innovative treatment strategies for blood and lymphatic cancers, contributing significantly to the advancement of knowledge and practice in this specialized area. Designed for researchers, healthcare professionals, and students alike, Blood and Lymphatic Cancer-Targets and Therapy aims to foster a deeper understanding of cancer biology and promote collaborative efforts leading to novel therapeutic interventions. The open-access model ensures that research findings are readily accessible to a global audience, underscoring the journal's commitment to enhancing patient care and fostering educational growth in the cancer domain.
Journal of Vascular Surgery-Venous and Lymphatic Disorders
Transforming research into practice for vascular professionals.The Journal of Vascular Surgery-Venous and Lymphatic Disorders, published by Elsevier, is a distinguished peer-reviewed journal dedicated to advancing the knowledge and practice of vascular surgery with a particular focus on venous and lymphatic conditions. With an ISSN of 2213-333X and a robust impact factor, this journal ranks Q2 in Cardiology and Cardiovascular Medicine and Q1 in Surgery, reflecting its high relevance and contribution to the field. Covering a wide spectrum of topics from innovative surgical techniques to the latest developments in venous and lymphatic disorders, the journal serves as a vital resource for researchers, clinicians, and students alike. It not only disseminates cutting-edge research but also promotes best practices and interdisciplinary collaboration within the cardiovascular domain. The journal is accessible to a global audience, ensuring that impactful findings reach practitioners and researchers everywhere, further elevating the standards of patient care and surgical excellence.
RHEUMATOLOGY INTERNATIONAL
Innovating clinical approaches for better patient care.Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.
PHLEBOLOGIE
Transforming Vascular Insights into Clinical PracticePHLEBOLOGIE is an esteemed journal published by GEORG THIEME VERLAG KG, serving as a critical platform for the dissemination of research in the field of Cardiology and Cardiovascular Medicine. Since its inception in 1991, the journal has consistently provided a comprehensive range of articles that explore the complexities of vascular health, offering insights into innovative treatments, diagnostic advancements, and emerging trends. Although currently not available as an Open Access publication, PHLEBOLOGIE maintains an impactful presence in the academic community, evident in its 2023 Scopus ranking as Q3 within its category and a percentile standing of 25%. Residing in Germany, PHLEBOLOGIE aims to bridge the gap between research and practice, appealing to researchers, clinicians, and students alike by fostering a deeper understanding of vascular conditions and their management.
Seminars in Pediatric Surgery
Transforming pediatric surgery through research and education.Seminars in Pediatric Surgery is a reputable journal published by Elsevier Science Inc, focusing on the dynamic and essential field of pediatric surgery. With an ISSN of 1055-8586 and E-ISSN 1532-9453, this journal is dedicated to advancing the knowledge and understanding of surgical practices in children, contributing valuable insights to both clinical and academic communities. Established in 1992, it has demonstrated its significance in medical education and research with a strong ranking in both the Q2 category for Pediatrics, Perinatology and Child Health and Surgery as of 2023. Additionally, its Scopus rankings reveal its reputable standing, placing it in the top 38% and 45% respectively among its peers in these specialties. Although the journal does not offer open access, it remains an essential resource for researchers, medical practitioners, and students wishing to stay abreast of innovative techniques, evolving practices, and groundbreaking research within pediatric surgery.
Phlebolymphology
Elevating the standards of research in vascular medicine.Phlebolymphology is a pivotal academic journal dedicated to advancing the field of vascular medicine, focusing on the intricate relationship between the venous and lymphatic systems. Published by Laboratoires Servier, this journal has been a significant platform for disseminating high-quality research and clinical findings since its inception in 1996, with coverage having extended from 1998 to 2017. Although it has discontinued its presence in Scopus, the journal remains a respected source within the realms of cardiology and cardiovascular medicine, currently ranked in the 19th percentile among its peers. While Phlebolymphology does not offer open access, its contributions are essential for practitioners, researchers, and educators looking to deepen their understanding of vascular diseases and treatments. With a commitment to promoting innovative research and clinical insights, Phlebolymphology plays an important role in shaping health care practices relating to venous and lymphatic health.